EUVIMEDEUVIMED entdecken
Crossref

β-Caryophyllene, a dietary phytocannabinoid, alleviates high-fat diet-induced hepatic steatosis in mice via AMPK activation

Ryosuke Kamikubo, Hiroki Yoshida, Taiki Fushimi, Yuki Kamei, Mitsugu Akagawa

Bioscience, Biotechnology, and Biochemistry · 2024

DOI: 10.1093/bbb/zbae129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2024. Verfasst von Ryosuke Kamikubo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, Division of Applied Life Sciences, Graduate School of Life and Environmental Sciences, Osaka Prefecture Universit…. Hauptthemen laut MEDLINE: Polycyclic Sesquiterpenes, Diet, High-Fat, Mice, Inbred C57BL, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: JSPS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

β-Caryophyllene (BCP), a dietary phytocannabinoid, significantly suppresses palmitate-induced lipid accumulation in human HepG2 hepatocytes via activation of AMP-activated protein kinase (AMPK) signaling. The objective of the preset research was to assess whether oral administration of BCP alleviates obesity-induced hepatic steatosis in mice through AMPK activation. We examined the protective action of supplementation of 0.3% BCP (w/w) in a high-fat diet (HFD) on C57BL/6J mice for 12 weeks. BCP supplementation evidently ameliorated histological hepatic steatosis features, and significantly reduced triglycerides and cholesterol levels in the liver, and serum levels of aspartate aminotransferase and alanine aminotransferase as compared with non-supplemented HFD-fed mice. Immunoblotting revealed that BCP supplementation in HFD-fed mice also caused hepatic AMPK activation. Furthermore, treatment with BCP in HFD-fed mice significantly suppressed body weight gain and attenuated obesity-related phenotypes relative to the HFD mice. Our results suggest the usefulness of BCP in the prevention of obesity-related liver steatosis and liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycyclic SesquiterpenesDiet, High-FatMice, Inbred C57BLAMP-Activated Protein KinasesFatty LiverLiverSesquiterpenesEnzyme ActivationAnimalsMaleMiceTriglyceridesObesityAlanine TransaminaseCholesterolAspartate AminotransferasesDietary SupplementsWeight Gain

Stichwörter der Autor:innen

AMPKNAFLDhepatic steatosisobesityβ-caryophyllene

Substanzen

caryophyllenePolycyclic SesquiterpenesAMP-Activated Protein KinasesSesquiterpenesTriglyceridesAlanine TransaminaseCholesterolAspartate Aminotransferases

Autor:innen und Institutionen

  • Department of Biological Chemistry, Division of Applied Life Sciences, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Sakai, Japan.
  • Department of Food and Nutrition, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.

Förderung

  • JSPS

Zitieren

APA

Kamikubo, R., Yoshida, H., Fushimi, T., Kamei, Y., & Akagawa, M. (2024). β-Caryophyllene, a dietary phytocannabinoid, alleviates high-fat diet-induced hepatic steatosis in mice via AMPK activation. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbae129

Vancouver

Kamikubo R, Yoshida H, Fushimi T, Kamei Y, Akagawa M. β-Caryophyllene, a dietary phytocannabinoid, alleviates high-fat diet-induced hepatic steatosis in mice via AMPK activation. Bioscience, Biotechnology, and Biochemistry. 2024. doi:10.1093/bbb/zbae129

BibTeX
@article{Kamikubo2024,
  author = {Kamikubo, Ryosuke and Yoshida, Hiroki and Fushimi, Taiki and Kamei, Yuki and Akagawa, Mitsugu},
  title = {β-Caryophyllene, a dietary phytocannabinoid, alleviates high-fat diet-induced hepatic steatosis in mice via AMPK activation},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2024},
  doi = {10.1093/bbb/zbae129}
}
Kostenlos starten →